DAVA Pharma
-
Endo International Purchasing Yet Another Pill Maker For $8.05 Billion
Following a prescription to break into the world’s top five generic pharmaceutical businesses, today Endo International (Nasdaq:ENDP) swallowed its fourth generics firm in recent months, buying…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
